Months after retiring from Genentech, Michael Varney brings his drug hunting eye to Frazier
Michael Varney began his post-Genentech career by taking a job as chairman of R&D at a biotech startup. Now he’s signed on for a new gig that will put him in direct contact with a whole lot more.
The biotech vet — who enjoyed a stellar reputation running Roche’s prestigious gRED organization in South San Francisco — is one of two freshly minted life sciences senior advisors at Frazier Healthcare Partners. Pfizer vet Don Frail has been tapped for the same role after most recently leading the external science and innovation team at Allergan.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.